Insight Molecular Diagnostics Inc. Cost of Revenue
Insight Molecular Diagnostics Inc. (IMDX) reported Cost of Revenue of $82.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. cost of revenue for the quarter ending 2026-06-30 was $82.00K, a 54.44% decline year-over-year.
- Insight Molecular Diagnostics Inc. cost of revenue for the quarter ending 2026-03-31 was $17.00K, a 97.91% decline year-over-year.
- Insight Molecular Diagnostics Inc. cost of revenue for the quarter ending 2025-12-31 was $643.00K, a 26.01% decline year-over-year.
- Insight Molecular Diagnostics Inc. cost of revenue for the quarter ending 2025-09-30 was $121.00K, a 181.40% increase year-over-year.
- Insight Molecular Diagnostics Inc. cost of revenue for fiscal 2025 was $1.75M, a 66.19% increase from fiscal 2024.
- Insight Molecular Diagnostics Inc. cost of revenue for fiscal 2024 was $1.05M, a 5.09% increase from fiscal 2023.
- Insight Molecular Diagnostics Inc. cost of revenue for fiscal 2023 was $1.00M, a 13.86% increase from fiscal 2022.
- Insight Molecular Diagnostics Inc. cost of revenue for fiscal 2022 was $880.00K, a 26.26% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $82.00K 10-Q · filed 2026-08-10 | $99.00K 10-Q · filed 2026-08-10 | $742.00K derived: sum of 3 quarters · filed 2026-08-10 | $863.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $17.00K 10-Q · filed 2026-05-13 | $660.00K derived: sum of 2 quarters · filed 2026-05-13 | $781.00K derived: sum of 3 quarters · filed 2026-05-13 | $961.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $643.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $764.00K derived: sum of 2 quarters · filed 2026-03-26 | $944.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.75M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $121.00K 10-Q · filed 2025-11-10 | $301.00K derived: sum of 2 quarters · filed 2026-08-10 | $1.11M 10-Q · filed 2025-11-10 | $1.98M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $180.00K 10-Q · filed 2026-08-10 | $168.00K 10-Q · filed 2025-08-11 | $993.00K 10-Q · filed 2026-08-10 | $974.00K 10-Q · filed 2025-08-11 | $1.86M derived: sum of 3 quarters · filed 2026-08-10 | $1.91M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $813.00K 10-Q · filed 2026-05-13 | $806.00K 10-Q · filed 2025-05-12 | $1.68M derived: sum of 2 quarters · filed 2026-05-13 | $1.73M derived: sum of 3 quarters · filed 2026-05-13 | $1.76M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $869.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $912.00K derived: sum of 2 quarters · filed 2026-03-26 | $944.00K derived: sum of 3 quarters · filed 2026-03-26 | $1.05M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $43.00K 10-Q · filed 2025-11-10 | $75.00K derived: sum of 2 quarters · filed 2025-11-10 | $184.00K 10-Q · filed 2025-11-10 | $593.00K derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $32.00K 10-Q · filed 2025-08-11 | $141.00K 10-Q · filed 2025-08-11 | $550.00K derived: sum of 3 quarters · filed 2025-08-11 | $709.00K derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $109.00K 10-Q · filed 2025-05-12 | $252.00K 10-Q · filed 2024-05-15 | $518.00K derived: sum of 2 quarters · filed 2025-05-12 | $677.00K derived: sum of 3 quarters · filed 2025-05-12 | $846.00K derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $568.00K derived: sum of 2 quarters · filed 2025-03-24 | $737.00K derived: sum of 3 quarters · filed 2025-03-24 | $1.00M 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | $159.00K 10-Q · filed 2024-11-12 | $328.00K derived: sum of 2 quarters · filed 2024-11-12 | $593.00K 10-Q · filed 2024-11-12 | $871.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $169.00K 10-Q · filed 2024-08-08 | $434.00K 10-Q · filed 2024-08-08 | $712.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.03M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $265.00K 10-Q · filed 2024-05-15 | $543.00K derived: sum of 2 quarters · filed 2024-05-15 | $857.00K derived: sum of 3 quarters · filed 2024-05-15 | $1.04M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $592.00K derived: sum of 2 quarters · filed 2024-04-16 | $775.00K derived: sum of 3 quarters · filed 2024-04-16 | $880.00K 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | $314.00K 10-Q · filed 2023-11-09 | $1.22M 10-Q · filed 2022-11-10 | $497.00K derived: sum of 2 quarters · filed 2023-11-09 | $602.00K 10-Q · filed 2023-11-09 | $3.64M 10-Q · filed 2022-11-10 | $2.82M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $183.00K 10-Q · filed 2023-08-10 | $1.41M 10-Q · filed 2022-08-12 | $288.00K 10-Q · filed 2023-08-10 | $2.43M 10-Q · filed 2022-08-12 | $2.51M derived: sum of 3 quarters · filed 2023-08-10 | $3.37M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $105.00K 10-Q · filed 2023-05-15 | $1.02M 10-Q · filed 2022-05-12 | $2.33M derived: sum of 2 quarters · filed 2023-05-15 | $3.19M derived: sum of 3 quarters · filed 2023-05-15 | $4.54M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $2.22M 10-K · filed 2022-03-11 | $3.08M derived: sum of 2 quarters · filed 2022-11-10 | $4.43M derived: sum of 3 quarters · filed 2022-11-10 | $697.00K 10-K · filed 2023-04-12 | $4.18M 10-K · filed 2022-03-11 | |||
| 2021-09-30 | $860.00K 10-Q · filed 2022-11-10 | $2.21M derived: sum of 2 quarters · filed 2022-11-10 | $2.95M 10-Q · filed 2022-11-10 | $3.66M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $1.35M 10-Q · filed 2022-08-12 | $2.09M 10-Q · filed 2022-08-12 | $2.80M derived: sum of 3 quarters · filed 2022-08-12 | $3.40M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $738.00K 10-Q · filed 2022-05-12 | $1.45M derived: sum of 2 quarters · filed 2022-05-12 | $2.06M derived: sum of 3 quarters · filed 2022-05-12 | $2.42M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $716.00K 10-K · filed 2022-03-11 | $1.32M derived: sum of 2 quarters · filed 2022-03-11 | $1.68M derived: sum of 3 quarters · filed 2022-03-11 | $1.85M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $601.00K 10-K · filed 2022-03-11 | $966.00K derived: sum of 2 quarters · filed 2022-03-11 | $1.14M 10-Q · filed 2021-11-09 | |||||
| 2020-06-30 | $365.00K 10-K · filed 2022-03-11 | $538.00K 10-Q · filed 2021-08-11 | ||||||
| 2020-03-31 | $173.00K 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |